Published in Hepatitis Weekly, May 26th, 2003
Researchers in Spain believe hepatocyte growth factor (HGF) controls angiogenesis in the inflamed liver of people with chronic hepatitis C by modulating growth factors known to regulate endothelial cell adhesion and migration. The knowledge of how proangiogenic mechanisms influence the pathogenesis of chronic hepatitis C could eventually lead investigators to the development of new treatment modalities.
In depth analyses of liver biopsies provided clues for how angiogenic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.